Filing Date | Form | Description | Issuer | View |
---|---|---|---|---|
DRS |
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
Intellia Therapeutics, Inc. | ||
DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Intellia Therapeutics, Inc. | ||
DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Intellia Therapeutics, Inc. | ||
DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Intellia Therapeutics, Inc. |
Data provided by Kaleidoscope.